• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C60 富勒烯对抗 SARS-CoV-2 冠状病毒:计算机模拟研究的新视角。

C fullerene against SARS-CoV-2 coronavirus: an in silico insight.

机构信息

Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine.

Institute of Molecular Biology and Genetics of NASU, Kyiv, 03143, Ukraine.

出版信息

Sci Rep. 2021 Sep 7;11(1):17748. doi: 10.1038/s41598-021-97268-6.

DOI:10.1038/s41598-021-97268-6
PMID:34493768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8423725/
Abstract

Based on WHO reports the new SARS-CoV-2 coronavirus is currently widespread all over the world. So far > 162 million cases have been confirmed, including > 3 million deaths. Because of the pandemic still spreading across the globe the accomplishment of computational methods to find new potential mechanisms of virus inhibitions is necessary. According to the fact that C fullerene (a sphere-shaped molecule consisting of carbon) has shown inhibitory activity against various protein targets, here the analysis of the potential binding mechanism between SARS-CoV-2 proteins 3CLpro and RdRp with C fullerene was done; it has resulted in one and two possible binding mechanisms, respectively. In the case of 3CLpro, C fullerene interacts in the catalytic binding pocket. And for RdRp in the first model C fullerene blocks RNA synthesis pore and in the second one it prevents binding with Nsp8 co-factor (without this complex formation, RdRp can't perform its initial functions). Then the molecular dynamics simulation confirmed the stability of created complexes. The obtained results might be a basis for other computational studies of 3CLPro and RdRp potential inhibition ways as well as the potential usage of C fullerene in the fight against COVID-19 disease.

摘要

基于世界卫生组织的报告,新型 SARS-CoV-2 冠状病毒目前在全球广泛传播。到目前为止,已经确诊了超过 1.62 亿例病例,包括超过 300 万人死亡。由于大流行仍在全球范围内蔓延,因此需要利用计算方法来寻找新的病毒抑制潜在机制。鉴于 C60 富勒烯(一种由碳组成的球形分子)已显示出对各种蛋白质靶标的抑制活性,我们在这里对 SARS-CoV-2 蛋白 3CLpro 和 RdRp 与 C60 富勒烯之间的潜在结合机制进行了分析;结果分别发现了一种和两种可能的结合机制。在 3CLpro 的情况下,C60 富勒烯与催化结合口袋相互作用。对于 RdRp,在第一个模型中,C60 富勒烯阻止 RNA 合成孔,在第二个模型中,它阻止与 Nsp8 辅助因子结合(如果没有这种复合物的形成,RdRp 就无法执行其初始功能)。然后,分子动力学模拟证实了所创建复合物的稳定性。这些结果可能为进一步研究 3CLPro 和 RdRp 的潜在抑制途径以及 C60 富勒烯在抗击 COVID-19 疾病方面的潜在用途提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/114bd95e2427/41598_2021_97268_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/4baf979fc758/41598_2021_97268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/13d410b1f773/41598_2021_97268_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/1cf27d754643/41598_2021_97268_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/0b58838cf274/41598_2021_97268_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/843d41975a7a/41598_2021_97268_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/73b42aa43b84/41598_2021_97268_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/114bd95e2427/41598_2021_97268_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/4baf979fc758/41598_2021_97268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/13d410b1f773/41598_2021_97268_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/1cf27d754643/41598_2021_97268_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/0b58838cf274/41598_2021_97268_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/843d41975a7a/41598_2021_97268_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/73b42aa43b84/41598_2021_97268_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf9/8423725/114bd95e2427/41598_2021_97268_Fig7_HTML.jpg

相似文献

1
C fullerene against SARS-CoV-2 coronavirus: an in silico insight.C60 富勒烯对抗 SARS-CoV-2 冠状病毒:计算机模拟研究的新视角。
Sci Rep. 2021 Sep 7;11(1):17748. doi: 10.1038/s41598-021-97268-6.
2
Anticoronavirus Activity of Water-Soluble Pristine C Fullerenes: In Vitro and In Silico Screenings.水溶性 Pristine C 富勒烯的抗冠状病毒活性:体外和计算机筛选。
Adv Exp Med Biol. 2021;1352:159-172. doi: 10.1007/978-3-030-85109-5_10.
3
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.鉴定 FDA 批准的针对 SARS-CoV-2 RNA 依赖性 RNA 聚合酶(RdRp)和 3-糜蛋白酶样蛋白酶(3CLpro)的药物,药物再利用方法。
Biomed Pharmacother. 2021 Jun;138:111544. doi: 10.1016/j.biopha.2021.111544. Epub 2021 Mar 31.
4
The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2.主要蛋白酶和RNA依赖性RNA聚合酶是新型冠状病毒的两个主要靶点。
Biochem Biophys Res Commun. 2021 Jan 29;538:63-71. doi: 10.1016/j.bbrc.2020.10.091. Epub 2020 Nov 21.
5
Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.采用计算方法筛选严重急性呼吸综合征冠状病毒 2 依赖 RNA 的 RNA 聚合酶抑制剂。
J Comput Biol. 2021 Dec;28(12):1228-1247. doi: 10.1089/cmb.2020.0639. Epub 2021 Nov 29.
6
Blue Biotechnology: Computational Screening of Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition.蓝色生物技术:基于计算的膜海松二萜类化合物对 SARS-CoV-2 主蛋白酶抑制作用的筛选
Mar Drugs. 2021 Jul 13;19(7):391. doi: 10.3390/md19070391.
7
Antiviral drug discovery: preparing for the next pandemic.抗病毒药物的发现:为下一次大流行做准备。
Chem Soc Rev. 2021 Mar 21;50(6):3647-3655. doi: 10.1039/d0cs01118e. Epub 2021 Feb 1.
8
Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M and PL of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations.结构洞察新冠病毒刺突糖蛋白、M 和 PL 与氰病毒-N 的结合:蛋白-蛋白相互作用、动力学模拟和自由能计算。
Molecules. 2021 Aug 24;26(17):5114. doi: 10.3390/molecules26175114.
9
RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.RNA 依赖性 RNA 聚合酶:COVID-19 的结构、机制与药物研发。
Biochem Biophys Res Commun. 2021 Jan 29;538:47-53. doi: 10.1016/j.bbrc.2020.08.116. Epub 2020 Sep 4.
10
Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations.通过分子动力学和结合自由能模拟探索 PF-07321332 SARS-CoV-2 蛋白酶抑制剂的结合机制。
Int J Mol Sci. 2021 Aug 24;22(17):9124. doi: 10.3390/ijms22179124.

引用本文的文献

1
Carbon-based nanomaterials against SARS-CoV-2: Therapeutic and diagnostic applications.用于对抗新型冠状病毒的碳基纳米材料:治疗与诊断应用
OpenNano. 2023 Mar;10:100121. doi: 10.1016/j.onano.2023.100121. Epub 2023 Feb 18.
2
Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment.对 SARS-CoV-2 的深入了解:用于 COVID-19 治疗的小分子杂合体。
Molecules. 2024 Nov 15;29(22):5403. doi: 10.3390/molecules29225403.
3
The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic.

本文引用的文献

1
Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study.与推荐的新冠病毒治疗药物相比,伊利马醌(海洋海绵代谢产物)作为一种新型的严重急性呼吸综合征冠状病毒2关键靶标蛋白抑制剂:设计、对接及分子动力学模拟研究
RSC Adv. 2020 Oct 13;10(62):37707-37720. doi: 10.1039/d0ra06379g. eCollection 2020 Oct 12.
2
Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.筛选海洋藻类代谢产物作为严重急性呼吸综合征冠状病毒2主蛋白酶(3CLpro)的高亲和力抑制剂:一项计算机模拟分析,以确定对抗新冠疫情的新型候选药物。
Appl Biol Chem. 2020;63(1):79. doi: 10.1186/s13765-020-00564-4. Epub 2020 Nov 21.
3
广谱生物活性化合物针对 COVID-19 大流行中 RNA 依赖性 RNA 聚合酶 (RdRp) 的功能意义。
Viruses. 2023 Nov 25;15(12):2316. doi: 10.3390/v15122316.
4
The Emergence of Carbon Nanomaterials as Effective Nano-Avenues to Fight against COVID-19.碳纳米材料作为对抗COVID-19的有效纳米途径的出现。
Materials (Basel). 2023 Jan 25;16(3):1068. doi: 10.3390/ma16031068.
5
Synthesis of [60]Fullerene Hybrids Endowed with Steroids and Monosaccharides: Theoretical Underpinning as Promising anti-SARS-CoV-2 Agents.含有类固醇和单糖的[60]富勒烯杂化物的合成:作为有前景的抗SARS-CoV-2药物的理论基础
European J Org Chem. 2023 Jan 18:e202201301. doi: 10.1002/ejoc.202201301.
6
Drummondin E and Flinderole B are potential inhibitors of RNA-dependent RNA polymerase of SARS-CoV-2: an study.德拉蒙丁E和弗林德洛尔B是新型冠状病毒RNA依赖性RNA聚合酶的潜在抑制剂:一项研究。
BioTechnologia (Pozn). 2022 Mar 24;103(1):53-70. doi: 10.5114/bta.2022.113915. eCollection 2022.
7
State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis.用于 SARS-CoV-2 诊断的最先进的智能纳米生物传感器。
Biosensors (Basel). 2022 Aug 13;12(8):637. doi: 10.3390/bios12080637.
8
Fullerene Derivatives for Drug Delivery against COVID-19: A Molecular Dynamics Investigation of Dendro[60]fullerene as Nanocarrier of Molnupiravir.用于对抗新冠病毒的药物递送的富勒烯衍生物:作为莫努匹拉韦纳米载体的树枝状[60]富勒烯的分子动力学研究
Nanomaterials (Basel). 2022 Aug 7;12(15):2711. doi: 10.3390/nano12152711.
9
Topological and Multivalent Effects in Glycofullerene Oligomers as EBOLA Virus Inhibitors.糖富勒烯低聚物作为埃博拉病毒抑制剂的拓扑和多价效应。
Int J Mol Sci. 2022 May 3;23(9):5083. doi: 10.3390/ijms23095083.
10
Fullerenes against COVID-19: Repurposing C and C to Clog the Active Site of SARS-CoV-2 Protease.富勒烯对抗 COVID-19:重新利用 C 和 C 以堵塞 SARS-CoV-2 蛋白酶的活性位点。
Molecules. 2022 Mar 16;27(6):1916. doi: 10.3390/molecules27061916.
Carbon-based antiviral nanomaterials: graphene, C-dots, and fullerenes. A perspective.碳基抗病毒纳米材料:石墨烯、碳点和富勒烯。综述
Chem Sci. 2020 Jun 16;11(26):6606-6622. doi: 10.1039/d0sc02658a. eCollection 2020 Jul 14.
4
C Fullerene Governs Doxorubicin Effect on Metabolic Profile of Rat Microglial Cells In Vitro.C 富勒烯调控阿霉素对体外大鼠小胶质细胞代谢谱的影响。
Mol Pharm. 2020 Sep 8;17(9):3622-3632. doi: 10.1021/acs.molpharmaceut.0c00691. Epub 2020 Jul 28.
5
Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.从 SARS-CoV-2 中天然产物的 RNA 依赖性 RNA 聚合酶抑制作用的系统发育分析和结构观点。
Interdiscip Sci. 2020 Sep;12(3):335-348. doi: 10.1007/s12539-020-00381-9. Epub 2020 Jul 3.
6
Structural plasticity of SARS-CoV-2 3CL M active site cavity revealed by room temperature X-ray crystallography.室温 X 射线晶体学揭示 SARS-CoV-2 3CL M 活性位点腔的结构可塑性。
Nat Commun. 2020 Jun 24;11(1):3202. doi: 10.1038/s41467-020-16954-7.
7
SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).SARS-CoV-2 和 SARS-CoV:针对 RNA 依赖性 RNA 聚合酶活性(NSP12)的潜在抑制剂的虚拟筛选。
J Med Virol. 2021 Jan;93(1):389-400. doi: 10.1002/jmv.26222. Epub 2020 Jul 9.
8
Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation.利用 3D 相似性搜索、分子对接、分子动力学和 ADMET 评估鉴定新型 SARS-CoV-2 3CLpro 和 RdRp 双靶标支架。
J Biomol Struct Dyn. 2021 Aug;39(12):4522-4535. doi: 10.1080/07391102.2020.1779130. Epub 2020 Jun 18.
9
Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2.潜在的 RNA 依赖性 RNA 聚合酶抑制剂作为对抗 SARS-CoV-2 的有前景的治疗方法。
J Med Microbiol. 2020 Jun;69(6):864-873. doi: 10.1099/jmm.0.001203. Epub 2020 May 29.
10
Structure of replicating SARS-CoV-2 polymerase.复制 SARS-CoV-2 聚合酶的结构。
Nature. 2020 Aug;584(7819):154-156. doi: 10.1038/s41586-020-2368-8. Epub 2020 May 21.